Paper17515386
Diffusion-weighted MRI in the body: applications and challenges in oncology.
Koh DM and 1 other. AJR Am J Roentgenol, 2007. Cited by 1,510 papers, by iCite.
Cite this record
ConductScience Library. Diffusion-weighted MRI in the body: applications and challenges in oncology. Papers, record 17515386. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17515386
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diffusion Magnetic Resonance Imaging | Major topic |
| Image Enhancement | Major topic |
| Image Interpretation, Computer-Assisted | Major topic |
| Medical Oncology | Major topic |
| Neoplasms | Major topic |
| Whole Body Imaging | Major topic |
| Adult | |
| Humans | |
| Male | |
| Prognosis |
Source PubMed
Trials5
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT03163316 | The Role of Magnetic Resonance Imaging in Assessment of Axillary Lymph Nodes Metastasis in Breast Cancer Patients. | Background | ClinicalTrials.gov | |
| NCT03961646 | Evaluation of the FOCUS Diffusion's Added Clinical Value Compared to Conventional MRI | Background | ClinicalTrials.gov | |
| NCT05097105 | Role of Diffusion -Weighted MRI in Evaluation of Urinary Bladder Masses | Background | ClinicalTrials.gov | |
| NCT05384535 | Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort | Background | ClinicalTrials.gov | |
| NCT05550090 | Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver MBC | Results | ClinicalTrials.gov |
Cited by716
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,510 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42961728 | High Spatial Resolution 23Na-MRI for Ischemic Brain Injury Detection. | Transl Stroke Res | 2026 | https://conductscience.org/library/papers/42961728 | PubMed |
| 42919290 | Three-dimensional multimodal fractal dynamics integrating spatial metabolism, cytoarchitecture, and perfusion for preoperative prediction of microvascular invasion in colorectal liver metastases. | J Transl Med | 2026 | https://conductscience.org/library/papers/42919290 | PubMed |
| 42898154 | An interim analysis of acute treatment adverse events and patient reported quality of life for functional imaging guided salivary gland sparing radiation therapy using diffusion-weighted magnetic resonance imaging. | Phys Imaging Radiat Oncol | 2026 | https://conductscience.org/library/papers/42898154 | PubMed |
| 42804146 | A preliminary evaluation of chest magnetic resonance imaging in adult patients with non-cystic fibrosis bronchiectasis. | Radiol Med | 2026 | https://conductscience.org/library/papers/42804146 | PubMed |
| 42758291 | Letter to the Editor: ADC as a non-invasive surrogate for PD-L1 in cervical cancer-addressing potential confounding and the leap to immunotherapy selection. | Eur Radiol | 2026 | https://conductscience.org/library/papers/42758291 | PubMed |
| 42758286 | Reply to the Letter to the Editor: ADC as a non-invasive surrogate for PD-L1 in cervical cancer-addressing potential confounding and the leap to immunotherapy selection. | Eur Radiol | 2026 | https://conductscience.org/library/papers/42758286 | PubMed |
| 42755601 | MRI-derived features reveal recurrence heterogeneity in VI-RADS 2 non-muscle-invasive bladder cancer. | Front Oncol | 2026 | https://conductscience.org/library/papers/42755601 | PubMed |
| 42732951 | Multi-pool Model-based Amide Proton Transfer Imaging for Tumor Characterization and Risk Stratification in Endometrial Carcinoma. | Magn Reson Med Sci | 2026 | https://conductscience.org/library/papers/42732951 | PubMed |
| 42696114 | Integrated model of MRI biomarkers and clinical factors for predicting pathologic response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer. | Abdom Radiol (NY) | 2026 | https://conductscience.org/library/papers/42696114 | PubMed |
| 42599582 | Diffusion-weighted magnetic resonance imaging as a promising technique for detection and follow-up of liver metastases from neuroendocrine tumors: a retrospective and prospective study from the NETTARE task force. | J Endocrinol Invest | 2026 | https://conductscience.org/library/papers/42599582 | PubMed |
| 42564379 | Corticosteroid-responsive portal lymphadenopathy mimicking malignant progression induced by furmonertinib in EGFR-mutated NSCLC: a case report. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42564379 | PubMed |
| 42437229 | Role of Whole-Body Magnetic Resonance Imaging in Detecting Metastasis in Patients With Known Cancer. | Cureus | 2026 | https://conductscience.org/library/papers/42437229 | PubMed |
| 42433582 | Impact of deep-learning image reconstruction on multiplexed sensitivity encoding diffusion-weighted imaging in the female pelvis. | Quant Imaging Med Surg | 2026 | https://conductscience.org/library/papers/42433582 | PubMed |
| 42412308 | Deep learning reconstruction-applied PROPELLER diffusion-weighted imaging in uterine malignancies: a comparison study with MUSE. | Jpn J Radiol | 2026 | https://conductscience.org/library/papers/42412308 | PubMed |
| 42381110 | Predictive imaging biomarkers on whole-body diffusion-weighted MRI (WB-DWMRI) and [68Ga]GaPSMA-PET/CT for [177Lu]LuPSMA therapy in metastatic prostate cancer (mCRPC). | Cancer Imaging | 2026 | https://conductscience.org/library/papers/42381110 | PubMed |
| 42243941 | Apparent diffusion coefficient and kurtosis parameters show early response to anti-angiogenic therapy in patients with colorectal liver metastases. | Cancer Imaging | 2026 | https://conductscience.org/library/papers/42243941 | PubMed |
| 42216654 | Collaborative Reconstruction of PROPELLER-EPI Data Using POCSMUSE (CORPUSE) for High-Fidelity Diffusion MRI. | Magn Reson Med | 2026 | https://conductscience.org/library/papers/42216654 | PubMed |
| 42209675 | Viscoelastic profiling of rare pediatric extracranial tumors using multifrequency MR elastography: a pilot study. | Sci Rep | 2026 | https://conductscience.org/library/papers/42209675 | PubMed |
| 42193007 | Radiological Features of Human Papillomavirus (HPV)-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma (OPSCC)-Considerations for Multimodal Analysis. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42193007 | PubMed |
| 42181386 | Subtle Enhancing Mural Thickening With Diffusion Restriction: An Early MRI Clue to Malignant Transformation in Ovarian Dermoid Cyst. | Cureus | 2026 | https://conductscience.org/library/papers/42181386 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17515386
GET https://conductscience.org/api/papers/v1/17515386/cited_by?page=2